Impact of Helicobacter pylori eradication therapy and low dose Aspirin on upper digestive tract mucosal injury among patients with coronary heart disease
LI Qun-shan1 SONG Bin2 LIANG Gui-ling2#br#
1.Department of Laboratory Medicine, Huizhou Traditional Chinese Medicine Hospital, Guangdong Province, Huizhou 516001, China;
2.Endoscopy Center, Huizhou Traditional Chinese Medicine Hospital, Guangdong Province, Huizhou 516001, China
Objective To investigate the impact of Helicobacter pylori eradication therapy (Hp) and low dose Aspirin on upper digestive tract mucosal injury among patients with coronary heart disease, and to provide evidence for making clinical decision.Methods A total of 105 patients combined with coronary heart disease and Hp infection were selected from January 2014 to December 2015 in our hospital.The patients were divided into Hp group (n=52) and control group (n=53) by using random number table method.Hp group received anti-Hp treatment according to standard protocol, and control group received routine treatment.The patients were followed up for 6 months, the occurrence of gastrointestinal symptoms and upper gastrointestinal mucosal injury were observe between two groups.Results The occurrence of gastrointestinal symptoms in Hp group and control group was 19.2% and 49.1% respectively;the occurrence of upper gastrointestinal mucosal injury in Hp group and control group was 7.7% and 22.6% respectively.The total occurrence rates of gastrointestinal symptoms and upper gastrointestinal mucosal injury were lower in Hp group than those in the control group, the differences were statistically significant (P<0.05).Conclusion To reduce the risk of gastrointestinal symptoms and upper gastrointestinal mucosal injury, patients combined with coronary atherosclerosis and Hp infectious should eradicate Hp infections.
Bardou M，Barkun AN.Preventing the gastrointestinal adverse effects of nonsteroidal anti-inflammatory drugs：from risk factor identification to risk factor intervention[J].Joint Bone Spine，2010，77（1）：6-12.
Lanza FL，Graham DY，Davis RE，et al.Endoscopic comparison of cimetidine and sucralfate for prevention of naproxen-induced acute gastroduodenal injury.effect of scoring method[J].Dig Dis Sci，1990，35（12）：1494-1499.
[7]
Sostres C，Lanas A.Gastrointestinal effects of aspirin[J].Nat Rev Gastroenterol Hepatol，2011，8（7）：385-394.
Iwamoto J，Saito Y，Honda A，et al.Clinical feature of gastroduodenal injury associated with long-term low dose aspirin therapy[J].World J Gastroenterol，2013，19（11）：1673-1682.
[10]
Cryer B，Bhatt DL，Lanza FL，et al.Low-dose aspirin-induced ulceration is attenuated by aspirin-phosphatidylcholine：a randomized clinical trial[J].Am J Gastroenterol，2011，106（2）：272-277.
[12]
Sokic-Milutinovic A，Krstic M，Rozer-Smolovic B，et al.Role of Helicobacter pylori infection in gastroduodenal damage in patients starting NSAID therapy：4 months follow-up study[J].Dig Dis Sci，2010，55（10）：2887-2892.
[13]
Bazzoli F，De Luca L，Graham DY.Helicobacter pylori infection and the use of NSAID[J].Best Paract Res Clin Gastroenterol，2001，15（5）：77-785.
[14]
Yeomans ND，Garas G，Hawkey CJ.Nonsteroidal anti-inflammatory drugs controcersy[J].Gastroenterol Clin North Am，2000，29（4）：791-805.
[15]
Schraier M，Petrelli L，Bonfanti M，et al.Experimental model of infection of Hilicobcter pylori in the mouse.a study of gastric damage caused by indomenthacin[J].Acta Gastroenterol Latinnoam，2001，31（3）：115-121.
[16]
Rybar I，Massaryk P，Mateicka F，et al.Nonsteroidal antiinflammatory drug induces mucosal lesions of the upper gastrointestinal tract and their relationship to Helicobacter pylori[J].Int J Clin Pharmacol Res，2001，21（3）：119-125.
京公网安备 11010502046607号